<?xml version="1.0" encoding="UTF-8"?>
<results title="compound">
 <result pre="as well as the anti-inflammatory activities of α-bisabolol, guajazulene, and" exact="chamazulene" post="have been reported in preclinical studies ( Viola et"/>
 <result pre="Omidbaigi et al., 2003, 2004; Bail et al., 2009), and" exact="propyl tiglate" post="(10.8–13.1%) ( Omidbaigi et al., 2003, 2004) or isobutyl"/>
 <result pre="propyl tiglate (10.8–13.1%) ( Omidbaigi et al., 2003, 2004) or" exact="isobutyl isobutyrate" post="(3.3%) ( Bail et al., 2009) or 2-butenyl angelate"/>
 <result pre="or isobutyl isobutyrate (3.3%) ( Bail et al., 2009) or" exact="2-butenyl angelate" post="(7.9–8.4%) ( Antonelli and Fabbri, 1998) or 2-methyl-2-propenyl angelate"/>
 <result pre="in samples Methyl tiglate 867 tr n-Hexanol 875 1.1 2-Methylbutyl" exact="acetate" post="897 0.4 Isobutyl isobutyrate 925 0.8 Acetonyl acetone 932"/>
 <result pre="1.1 2-Methylbutyl acetate 897 0.4 Isobutyl isobutyrate 925 0.8 Acetonyl" exact="acetone" post="932 0.7 α-Pinene 935 2.4 Camphene + allyl methacrylate"/>
 <result pre="969 0.3 Myrcene 973 0.6 Propyl angelate 993 1.1 Isobutyl" exact="2-methylbutyrate" post="998 tr Isoamyl isobutyrate 1,004 1.5 2-Methylbutyl isobutyrate 1,006"/>
</results>
